SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-348354
Filing Date
2018-12-13
Accepted
2018-12-13 09:19:31
Documents
5
Effectiveness Date
2018-12-13

Document Format Files

Seq Description Document Type Size
1 S-8 d666481ds8.htm S-8 69122
2 EX-5.1 d666481dex51.htm EX-5.1 12977
3 EX-23.1 d666481dex231.htm EX-23.1 1825
4 GRAPHIC g666481page132.jpg GRAPHIC 2938
5 GRAPHIC g666481page133.jpg GRAPHIC 2031
  Complete submission text file 0001193125-18-348354.txt   92032
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228772 | Film No.: 181232292
SIC: 2834 Pharmaceutical Preparations